Redefining strategies to introduce tolerance inducing cellular therapy in humans to combat autoimmunity and transplantation reactions
Clinical translation of tolerance-inducing cell therapies requires a novel approach focused on innovative networks, patient involvement and, foremost, a fundamental paradigm shift in thinking from both Academia, Industry and Regulatory Agencies. Tolerance-inducing cell products differ essentially f...
Main Authors: | Anja eTen Brinke, Irma eJoosten, S. Marieke evan Ham, Cees evan Kooten, Berent Jan Prakken |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-08-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fimmu.2014.00392/full |
Similar Items
-
Ways Forward for Tolerance-Inducing Cellular Therapies- an AFACTT Perspective
by: Anja ten Brinke, et al.
Published: (2019-02-01) -
Co-Stimulation-Impaired Bone Marrow-Derived Dendritic Cells Prevent Dextran Sodium Sulfate-Induced Colitis in Mice
by: Carl Engman, et al.
Published: (2018-05-01) -
The similarities between smDCs and regDCs in alleviating the immune injury caused by transplantation of hepatocytes differentiated from ESCs
by: Cheng Zhang, et al.
Published: (2017-11-01) -
Nutraceuticals as Potential Therapeutic Modulators in Immunometabolism
by: Gonzalo Alba, et al.
Published: (2023-01-01) -
The emerging role of regulatory cell-based therapy in autoimmune disease
by: Farbod Ghobadinezhad, et al.
Published: (2022-12-01)